SAD, Safety, PK of ASP3700 in healthy male subjects, plus a DDI part

• Research type

  Research Study

• Full title

  A Phase 1, Single Ascending Oral Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP3700 in Healthy Male Subjects, Including a Drug drug Interaction Part with Itraconazole

• IRAS ID

  152101

• Contact name

  Annelize Koch

• Contact email

  annelize.koch@parexel.com

• Sponsor organisation

  Astellas Pharma Europe BV

• Eudract number

  2013-005018-36

• REC name

  London - Westminster Research Ethics Committee

• REC reference

  14/LO/0499

• Date of REC Opinion

  30 Apr 2014

• REC opinion

  Further Information Favourable Opinion